ALDH1 in Combination with CD44 as Putative Cancer Stem Cell Markers are Correlated with Poor Prognosis in Urothelial Carcinoma of the Urinary Bladder

Keymoosi, Hossein; Gheytanchi, Elmira; Asgari, Mojgan; Shariftabrizi, Ahmad; Madjd, Zahra

추천

검색

자료유형: 학술저널

저자정보: Keymoosi, Hossein (Department Pathology, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences) Gheytanchi, Elmira (Oncopatholgy Research Centre, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences) Asgari, Mojgan (Department Pathology, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences) Shariftabrizi, Ahmad (Department of Pathology, Tufts University School of Medicine) Madjd, Zahra (Department Pathology, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제15권 제5호

발행연도: 2014.1

수록면: 2,013 - 2,020 (8page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: The aldehyde dehydrogenase 1 family member A1 (ALDH1A1) is one of the promising markers for identifying cancer stem cells in many cancer types, along with other markers including CD44. The aim of the present study was to evaluate the expression and clinical significance of putative cancer stem cell markers, CD44 and ALDH1A1, in a series of urothelial carcinomas of urinary bladder (UCUB) by tissue microarray (TMA). Materials and Methods: A total of 159 Urothelial Carcinomas (UC) including 96 (60%) low grade and 63 (40%) high grade carcinomas were immunohistochemically examined for the expression of CD44 and ALDH1A1. Correlations of the relative expression of these markers with clinicopathological parameters were also assessed. Results: High level expression of ALDH1A1 was found in 16% (25/159) of bladder UC which was significantly correlated with increased tumor size (p value=0.002), high grade (p value<0.001), pathologic stage (T1, p value=0.007 and T2, p value<0.001) and increased rate of recurrence (p value=0.013). A high level of CD44 expression was found in 43% (68/159) of cases, being positively correlated with histologic grade (p value=0.032) and recurrence (p value=0.039). Conclusions: Taken together, our results showed that ALDH1 was concurrently expressed in a fraction of CD44+ tumors and its expression correlated with poor prognosis in UCs. ALDH1A1 could be an ideal marker for targeted therapy of UCs in combination with conventional therapies, particularly in patients with high grade carcinomas. These findings indicate that cells expressing ALDH1A1 along with CD44 can be a potential therapeutic target in bladder carcinomas.

#ALDH1A1 #CD44 #TMA #bladder carcinoma #targeted therapy

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

이 논문의 저자 정보

Keymoosi, Hossein

소속기관 Department Pathology, Faculty of Advanced Technologies in Medicine, Iran University of Medical Scien